Clinical Research.

Our mission is to detect the earliest signs of heart and blood vessel damage

with a view to preventing serious complications later.

Our main focus for prevention of atherosclerosis is for children and young adults with risk factors for early heart disease, especially those who are obese, those exposed to passive smoke in the home, those who smoke themselves or those who with high levels of cholesterol. We are also focussing on subjects with pre-diabetes or diabetes and babies who are born small at full term. 

What impact will this research have?

Early detection and prevention of advanced heart disease could save hundreds of thousands of lives each year.

Professor David Celermajer
Research group led by:
Research covers areas of:
What’s new in the lab?

Mentoring the next generation of scientists

Recently, ten bright young researchers from New Zealand took part in a summer scholarship at the HRI to get hands-on experience in our world-class laboratory facilities and to be mentored by leaders in the cardiovascular disease research field. They share their experiences here.
Current team update

For his work on early detection of pulmonary vascular disease, Dr Edmund Lau won the Young Investigator Award from the Thoracic Society of ANZ as well as from the Pulmonary Hypertension Society of ANZ 

Jan 07, 2015

Help fund vital research into heart disease

Select your donation details
You can choose between donating once or monthly.
Please enter or select your donation amount.
Invest in a future free from cardiovascular disease.
Your donation will allow great science to flourish.
All donations are tax deductible.